27 février 2024
Bertelsmann Investments acquires the pharmaceutical technology company EXTEDO for a double-digit million amount. A Taylor Wessing team led by the two partners Dr Gregor Schmid (Berlin) and Dr Niclas von Woedtke (Hamburg) advised Bertelsmann Investments on all legal issues in connection with the acquisition.
Bertelsmann Investments is the investment arm of Bertelsmann and has invested around €1.7 billion in over 400 innovative companies and funds to date. The venture capital company currently holds shares in more than 360 innovative companies and funds, particularly in the fields of education, digital media, fintech, e-commerce and adtech. The acquisition of EXTEDO expands Bertelsmann Investments' portfolio of companies with the aim of strategically expanding its position in the European growth market of pharma tech through synergies with existing portfolio companies. As a leading provider of software solutions and services in the field of regulatory information, EXTEDO brings extensive expertise to the table, which both industry customers and public authorities can draw on.par plusieurs auteurs
par plusieurs auteurs
par plusieurs auteurs